Yuhan Corporation
000100
Κατάταξη σε μετοχές
#3833
Yuhan Corporation, a prominent South Korean pharmaceutical firm established in... Yuhan Corporation, a prominent South Korean pharmaceutical firm established in 1926 and headquartered in Seoul, specializes in the research, development, and manufacture of active pharmaceutical ingredients (APIs) and intermediates for both domestic and international markets. Its extensive product portfolio encompasses a wide array of prescription pharmaceuticals (ETC), addressing therapeutic areas such as cardiovascular, alimentary, genito-urinary, metabolic, respiratory, allergy, and neurological systems, alongside anti-infectives, anti-cancer treatments, and hormonal therapies. Notable offerings include Revanex, an acid pump antagonist designed for treating peptic ulcers and gastritis-related mucosal injury. Beyond prescription drugs, Yuhan Corporation provides a diverse range of over-the-counter (OTC) medications, including vitamins, mineral supplements, hepatopathy treatments, tonics, and drugs for respiratory, alimentary, dermatological, and pain relief applications. The company also extends its reach into consumer health and household goods, producing items like bleaches, detergents, pesticides, and oral care products. Further diversifying its operations, Yuhan is involved in the dental sector, supplying implants, equipment, consumables, and dental care solutions, and manufactures veterinary medical supplies for livestock, aquatic species, and companion animals. Additionally, it offers contract manufacturing services to other businesses.
Τιμή μετοχής
$63.22
Κεφαλαιοποίηση
$4.27B
Αλλαγή (1 ημέρα)
-3.12%
Αλλαγή (1 έτος)
-23.57%
Χώρα
KR
Εμπόριο Yuhan Corporation (000100)
Κατηγορία
Healthcare
Δείκτης P/B για Yuhan Corporation (000100)
Δείκτης P/B στις October 2026 TTM: 3.01
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της Yuhan Corporation, ο τρέχων δείκτης P/B (TTM) είναι 3.01. Στο τέλος του 2024, η εταιρεία είχε P/B δείκτη 4.26.
Ιστορικό P/B για την Yuhan Corporation από 2007 έως 2026
Δείκτης P/B στο τέλος κάθε έτους
| Έτος | Δείκτης P/B | Αλλαγή |
|---|---|---|
| 2026 (TTM) | 3.01 | -23.89% |
| 2025 | 3.95 | -7.28% |
| 2024 | 4.26 | 66.37% |
| 2023 | 2.56 | 24.28% |
| 2022 | 2.06 | -6.66% |
| 2021 | 2.21 | -17.25% |
| 2020 | 2.67 | 56.39% |
| 2019 | 1.71 | 23.87% |
| 2018 | 1.38 | -0.40% |
| 2017 | 1.38 | 6.44% |
| 2016 | 1.30 | -33.49% |
| 2015 | 1.96 | 49.31% |
| 2014 | 1.31 | -13.72% |
| 2013 | 1.52 | 4.85% |
| 2012 | 1.45 | 25.35% |
| 2011 | 1.15 | -32.24% |
| 2010 | 1.70 | -8.86% |
| 2009 | 1.87 | -22.38% |
| 2008 | 2.41 | -0.50% |
| 2007 | 2.42 | 0.00% |
Δείκτης P/B για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Δείκτης P/B | Διαφορά Δείκτη P/B | Χώρα |
|---|---|---|---|
| 1.9834 | -34.03% |
DE
|
|
| 2.1139 | -29.69% |
DE
|
|
| 1.3124 | -56.35% |
JP
|
|
| 6.3468 | 111.10% |
CH
|
|
| 5.0287 | 67.26% |
IN
|
